Features: |
An ester formed by the condensation of gallic acid and propanol. Propyl gallate (PG), chemically known as propyl-3,4,5-trihydroxybenzoate, is widely present in processed food and cosmetics, hair products, and lubricants. PG alone demonstrated antioxidative and cytoprotective properties against cellular damage and gained a pro-oxidative property in combination with copper (II). It was reported that PG was one of the most active compounds capable of generating H2O2 in DMEM media |
1763- | PG,  |   | Generation of Hydrogen Peroxide in Cancer Cells: Advancing Therapeutic Approaches for Cancer Treatment |
- | Review, | NA, | NA |
1764- | PG,  | Cu,  |   | DNA strand break induction and enhanced cytotoxicity of propyl gallate in the presence of copper(II) |
- | in-vitro, | Nor, | GM05757 |
1765- | PG,  |   | Enhanced cell death effects of MAP kinase inhibitors in propyl gallate-treated lung cancer cells are related to increased ROS levels and GSH depletion |
- | in-vitro, | Lung, | A549 | - | in-vitro, | Lung, | Calu-6 |
1766- | PG,  |   | Propyl gallate induces human pulmonary fibroblast cell death through the regulation of Bax and caspase-3 |
- | in-vitro, | Nor, | NA |
1767- | PG,  |   | Propyl gallate induces cell death in human pulmonary fibroblast through increasing reactive oxygen species levels and depleting glutathione |
- | in-vitro, | Nor, | NA |
1768- | PG,  |   | Propyl gallate reduces the growth of lung cancer cells through caspase‑dependent apoptosis and G1 phase arrest of the cell cycle |
- | in-vitro, | Lung, | Calu-6 | - | in-vitro, | Lung, | A549 |
1769- | PG,  |   | The Anti-Apoptotic Effects of Caspase Inhibitors in Propyl Gallate-Treated Lung Cancer Cells Are Related to Changes in Reactive Oxygen Species and Glutathione Levels |
- | in-vitro, | Lung, | Calu-6 | - | in-vitro, | Lung, | A549 |
1770- | PG,  |   | Propyl gallate sensitizes human lung cancer cells to cisplatin-induced apoptosis by targeting heme oxygenase-1 for TRC8-mediated degradation |
- | in-vitro, | Lung, | NA |
1771- | PG,  |   | Pharmacokinetic and toxicological overview of propyl gallate food additive |
- | Human, | Nor, | NA |
1772- | PG,  |   | Propyl gallate decreases the proliferation of Calu-6 and A549 lung cancer cells via affecting reactive oxygen species and glutathione levels |
- | in-vitro, | Lung, | Calu-6 | - | in-vitro, | Lung, | A549 |
1774- | PG,  |   | Geno- and cytotoxicity of propyl gallate food additive |
- | in-vitro, | Lung, | A549 |
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:138 Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid